REQUEST A DEMO
Total
USD $0.00
Search more companies

I.P.S. Medicor Ltda. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Ambulatory Health Care Services | Diagnostic Imaging Centers | General Medical and Surgical Hospitals
Full name: I.P.S. Medicor Ltda. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

I.P.S. Medicor Ltda. is an enterprise based in Colombia. Its main office is in Monteria. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 07, 1998. From the latest financial highlights, I.P.S. Medicor Ltda. reported a net sales revenue increase of 76.68% in 2022. Its’ total assets recorded a negative growth of 20.35%. The net profit margin of I.P.S. Medicor Ltda. decreased by 11.25% in 2022.

Headquarters
Calle 38 N 8 69
Monteria; Cordoba;

Contact Details: Purchase the I.P.S. Medicor Ltda. report to view the information.

Basic Information
Outstanding Shares:
Purchase the I.P.S. Medicor Ltda. report to view the information.
Incorporation Date:
April 07, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after I.P.S. Medicor Ltda. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
76.68%
Total operating revenue
76.68%
Operating profit (EBIT)
57.21%
Net Profit (Loss) for the Period
-34.58%
Total assets
-20.35%
Total equity
31.86%
Operating Profit Margin (ROS)
-2.09%
Net Profit Margin
-11.25%
Return on Equity (ROE)
-10.46%
Quick Ratio
6.29%
Cash Ratio
0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?